Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies-Reference-Cited by-同舟云学术

Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies

Published:2018-03-26 Issue:5 Volume:67 Page:1797-1806
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Simon Tracey G.¹²³⁴^ORCID,King Lindsay Y.⁵,Chong Dawn Q.⁶,Nguyen Long H.¹²³⁴,Ma Yanan³⁷⁸,VoPham Trang³⁹⁸,Giovannucci Edward L.³⁹¹⁰⁸,Fuchs Charles S.¹¹,Meyerhardt Jeffrey A.³¹²,Corey Kathleen E.¹²³⁴,Khalili Hamed²³⁴,Chung Raymond T.¹²³,Zhang Xuehong³⁸^ORCID,Chan Andrew T.²³⁴⁸

Affiliation:

1. Liver Center, Division of Gastroenterology, Department of Medicine; Massachusetts General Hospital; Boston MA

2. Division of Gastroenterology, Department of Medicine; Massachusetts General Hospital; Boston MA

3. Harvard Medical School; Boston MA

4. Clinical and Translational Epidemiology Unit (CTEU), Massachusetts General Hospital; Boston MA

5. Division of Gastroenterology and Hepatology; Duke University; Durham NC

6. National Cancer Centre Singapore; Singapore

7. Department of Biostatistics and Epidemiology; School of Public Health, China Medical University; Shenyang Liaoning China

8. Channing Division of Network Medicine, Department of Medicine; Brigham and Women's Hospital; Boston MA

9. Department of Epidemiology; Harvard T.H. Chan School of Public Health; Boston MA

10. Department of Nutrition; Harvard T.H. Chan School of Public Health; Boston MA

11. Yale University Cancer Center; New Haven CT

12. Dana-Farber Cancer Center; Boston MA

Funder

Nurses' Health Study infrastructure grant

Nurses' Health Study program grant for cancer research

Health Professionals Follow Up Study infrastructure grant

NIH

Career development award

American Gastroenterological Association

Publisher

Wiley

Subject

Hepatology

Reference51 articles.

1. Update of mortality attributable to diabetes for the IDF Diabetes Atlas: estimates for the year 2011;International Diabetes Federation Diabetes Atlas Group;Diabetes Res Clin Pract,2013

2. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012;Geiss;JAMA,2014

3. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults;Calle;N Engl J Med,2003

4. Diabetes and cancer: a consensus report;Giovannucci;Diabetes Care,2010

5. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort;Schlesinger;Ann Oncol,2013

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of physical activity, including amount and maintenance, with the risk of HCC among patients with type 2 diabetes;JHEP Reports;2024-10

2. Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-09

3. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

4. AI‐powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient‐specific risk factors;Liver International;2024-07-24

5. Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients;Hepatology International;2024-07-16